✦ LIBER ✦

Tailoring Tyrosine Kinase Inhibitors to Fit the Lung Cancer Genome

✍ Scribed by Looyenga, Brendan D.; Cherni, Irene; MacKeigan, Jeffrey P.; Weiss, Glen J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Emerging Paradigms in the Development of

✍ Gainor, J. F.; Shaw, A. T. 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 162 KB

Subsequent chemotherapy reverses acquire

✍ Renhua Guo; Xiaofen Chen; Tongshan Wang; Zhiyuan Zhang; Jin Sun; Yongqian Shu 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 307 KB

Mechanisms of acquired resistance to EGF

✍ Ji, Wonjun; Choi, Chang-Min; Rho, Jin; Jang, Se; Park, Young; Chun, Sung-Min; Ki 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 506 KB

The tyrosine kinase inhibitor imatinib f

✍ Jie Chen; Christoph Röcken; Barbara Nitsche; Christian Hosius; Harald Gschaidmei 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 236 KB

ALDH-positive lung cancer stem cells con

✍ Cheng-Po Huang; Meng-Feng Tsai; Tzu-Hua Chang; Wei-Chien Tang; Su-Yu Chen; Hsiao 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 802 KB

Molecular predictors of response to tyro

✍ Samuel Murray, Vasilios Karavasilis… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 477 KB